Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Chaisson

Showing results (31-40 of 241) with videos related to

Pageof 25
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2015
Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?Jean-Philippe Lanoix, Richard E Chaisson, Eric L Nuermberger
AIDS (London, England)|July 1, 2009
Additive effects of isoniazid preventive therapy and HAARTJonathan E Golub, Richard E Chaisson, Neil A Martinson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2003
Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicityTimothy R Sterling, Richard E Chaisson, Richard D Moore
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2004
Differences in HIV disease progression by injecting drug use in HIV-infected persons in careRichard D Moore, Jeanne C Keruly, Richard E Chaisson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2010
HIV infection-related tuberculosis: clinical manifestations and treatmentTimothy R Sterling, Paul A Pham, Richard E Chaisson
Proceedings of the American Thoracic Society|June 10, 2011
Epidemiology of tuberculosis and HIV: recent advances in understanding and responsesNeil A Martinson, Christopher J Hoffmann, Richard E Chaisson
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 13, 2014
Tuberculosis preventive therapy: an underutilised strategy to reduce individual risk of TB and contribute to TB controlGavin J Churchyard, Richard E Chaisson, Gary Maartens, et al.
The Journal of Infectious Diseases|August 30, 2007
Tuberculosis preventive therapy in the era of HIV infection: overview and research prioritiesGavin J Churchyard, Fabio Scano, Alison D Grant, et al.
The Journal of Infectious Diseases|November 26, 2003
Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort studyTimothy R Sterling, Richard E Chaisson, Jeanne Keruly, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2012
Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemicsDavid W Dowdy, Jonathan E Golub, Richard E Chaisson, et al.
Pageof 25

Showing results (31-40 of 241) with videos related to

Sort By:
Pageof 25
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2015
Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?Jean-Philippe Lanoix, Richard E Chaisson, Eric L Nuermberger
AIDS (London, England)|July 1, 2009
Additive effects of isoniazid preventive therapy and HAARTJonathan E Golub, Richard E Chaisson, Neil A Martinson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2003
Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicityTimothy R Sterling, Richard E Chaisson, Richard D Moore
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2004
Differences in HIV disease progression by injecting drug use in HIV-infected persons in careRichard D Moore, Jeanne C Keruly, Richard E Chaisson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2010
HIV infection-related tuberculosis: clinical manifestations and treatmentTimothy R Sterling, Paul A Pham, Richard E Chaisson
Proceedings of the American Thoracic Society|June 10, 2011
Epidemiology of tuberculosis and HIV: recent advances in understanding and responsesNeil A Martinson, Christopher J Hoffmann, Richard E Chaisson
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 13, 2014
Tuberculosis preventive therapy: an underutilised strategy to reduce individual risk of TB and contribute to TB controlGavin J Churchyard, Richard E Chaisson, Gary Maartens, et al.
The Journal of Infectious Diseases|August 30, 2007
Tuberculosis preventive therapy in the era of HIV infection: overview and research prioritiesGavin J Churchyard, Fabio Scano, Alison D Grant, et al.
The Journal of Infectious Diseases|November 26, 2003
Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort studyTimothy R Sterling, Richard E Chaisson, Jeanne Keruly, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2012
Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemicsDavid W Dowdy, Jonathan E Golub, Richard E Chaisson, et al.
Pageof 25